Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
60
Views
45
CrossRef citations to date
0
Altmetric
Original Research

Salvage treatment with apatinib for advanced non-small-cell lung cancer

Zhengbo Song1 Department of Chemotherapy, Zhejiang Cancer Hospital;2 Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou, People’s Republic of China
,
Xinmin Yu1 Department of Chemotherapy, Zhejiang Cancer Hospital;2 Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
,
Guangyuan Lou1 Department of Chemotherapy, Zhejiang Cancer Hospital;2 Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou, People’s Republic of China
,
Xun Shi1 Department of Chemotherapy, Zhejiang Cancer Hospital;2 Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou, People’s Republic of China
&
Yiping Zhang1 Department of Chemotherapy, Zhejiang Cancer Hospital;2 Key Laboratory Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang province, Hangzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
Pages 1821-1825 | Published online: 23 Mar 2017

References

  • ChenWZhengRBaadePDCancer statistics in China, 2015CA Cancer J Clin201666211513226808342
  • MitsudomiTMoritaSYatabeYWest Japan Oncology GroupGefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialLancet Oncol201011212112820022809
  • ZhouCWuYLChenGErlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncol201112873574221783417
  • MokTSWuYLThongprasertSGefitinib or carboplatin paclitaxel in pulmonary adenocarcinomaN Engl J Med200936194795719692680
  • ShawATKimDWNakagawaKCrizotinib versus chemotherapy in advanced ALK-positive lung cancerN Engl J Med2013368252385239423724913
  • SongZZhangYRetreatment with pemetrexed chemotherapy in advanced non-small cell lung cancer patientJ Thorac Dis2014685686024977013
  • GaronEBCiuleanuTEArrietaORamucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trialLancet2014384994466567324933332
  • HallRDLeTMHaggstromDEGentzlerRDAngiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)Transl Lung Cancer Res2015451552326629420
  • HanrahanEOHeymachJVVascular endothelial growth factor receptor tyrosine kinase inhibitors vandetanib (ZD6474) and AZD2171 in lung cancerClin Cancer Res20071315 pt 2s4617s462217671152
  • SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med2006355242542255017167137
  • ReckMvon PawelJZatloukalPPhase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAilJ Clin Oncol20092781227123419188680
  • ScottAJMessersmithWAJimenoAApatinib: a promising oral antiangiogenic agent in the treatment of multiple solid tumorsDrugs Today (Barc)201551422322926020064
  • LiJQinSXuJApatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trialJ Clin Oncol201331263219322523918952
  • LiJQinSXuJRandomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctionJ Clin Oncol201634131448145426884585
  • ZhangKShiMHuangCA phase II, multicenter, placebo-controlled trial of apatinib in patients with advanced nonsquamous non-small cell lung cancer (NSCLC) after two previous treatment regimensJ Clin Oncol201015suppl7548
  • SunJMLeeKWKimJHEfficacy and toxicity of pemetrexed as a third-line treatment for non-small cell lung cancerJpn J Clin Oncol200839273218952704
  • GirardNJacouletPGainetMThird-line chemotherapy in advanced non-small cell lung cancer: identifying the candidates for routine practiceJ Thorac Oncol20094121544154919884862
  • DingJChenXGaoZMetabolism and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor apatinib in humansDrug Metab Dispos2013411195121023509226
  • AzizMASeryaRALasheenDSDiscovery of potent VEGFR-2 inhibitors based on furopyrimidine and thienopyrimidne scaffolds as cancer targeting agentsSci Rep201662446027080011
  • ZhangHQGongFHLiCGDesign and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitorsEur J Med Chem201610937137926826581
  • GhavamipourFShahangianSSSajediRHArabSSMansouriKAghamaaliMRDevelopment of a highly-potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding siteFEBS J2014281194479449425132001
  • HuXZhangJXuBMulticenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancerInt J Cancer201413581961196924604288
  • DingLLiQJYouKYJiangZMYaoHRThe use of apatinib in treating nonsmall-cell lung cancer: case report and review of literatureMedicine (Baltimore)20169520e359827196461
  • ShepherdFADanceyJRamlauRProspective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapyJ Clin Oncol200018102095210310811675
  • SetoTKatoTNishioMErlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 studyLancet Oncol201415111236124425175099

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.